Timely and relevant thoracic oncology news brought to you by the only global association dedicated to the multidisciplinary study of lung cancer.

Timely and relevant thoracic oncology news brought to you by the only global association dedicated to the multidisciplinary study of lung cancer.

Search results for: “patient perspective”

  • NCI Corner – Interview with Dinah S. Singer, PHD

    NCI Corner – Interview with Dinah S. Singer, PHD

    By

    Regulatory Agency Perspective

    By Erik J. MacLaren, PhD Blue Ribbon Panel of the US National Cancer Advisory BoardDuring his State of the Union address in January 2016, President Barack Obama announced a new effort led by Vice President Joe Biden to accelerate research into cancer, known as the Vice President’s Cancer Initiative, or the National Cancer Moonshot.1 Among…

  • Small Cell Lung Cancer: The Next Challenge

    Small Cell Lung Cancer: The Next Challenge

    By

    Regulatory Agency Perspective

    By Peter Ujhazy, MD, PhD The newfound optimism in the management of lung cancer that infused the research, clinical, and patient communities 12 years ago is still gaining momentum. Seminal findings on the predictive value of epidermal growth factor receptor mutations1,2 were followed by discoveries of other therapeutic targets (ALK, ROS1, BRAF, etc.) and by…

  • Paul A. Bunn, Jr, MD: Recipient of 2016 Karnofsky Award

    Paul A. Bunn, Jr, MD: Recipient of 2016 Karnofsky Award

    By

    Uncategorized

    The David A. Karnofsky Memorial Award from the American Society of Clinical Oncology (ASCO) recognizes oncologists who have made outstanding contributions to the research, diagnosis, or treatment of cancer. Dr. Paul A. Bunn, Jr, Distinguished Professor, Division of Medical Oncology/ University of Colorado, James Dudley Chair in Lung Cancer Research, is the 2016 Karnofsky Award…

  • Interview with Richard Pazdur, MD

    Interview with Richard Pazdur, MD

    By

    Regulatory Agency Perspective

    New oncology drugs have, for decades, followed a well-trodden path of sequential clinical trials to get from the laboratory to the patient. This model has proven its worth by delivering effective new treatments while also protecting patient safety, but newer “seamless” trial designs have the potential to modernize the drug testing process and allow patients…

  • FDA Corner – Interview with Gideon Blumenthal, MD

    FDA Corner – Interview with Gideon Blumenthal, MD

    By

    Regulatory Agency Perspective

    By Erik J. Mac Laren, PhD In 2015, the US Food and Drug Administration (FDA) approved an unprecedented 7 new drugs or new uses for drugs for patients with lung cancer, an increase driven by the proliferation of targeted therapies in the area of thoracic oncology. The advent of precision medicine in oncology has raised…

  • NCI Corner – Interview with Shakun Malik, MD

    NCI Corner – Interview with Shakun Malik, MD

    By

    Regulatory Agency Perspective

    By Erik J. Mac Laren, PhD In late 2015, the US National Cancer Institute (NCI) Thoracic Malignancy Steering Committee (TMSC) published its strategic priorities for the coming years. These include: (1) innovative clinical trials to facilitate the development of immunotherapies and targeted therapies; (2) rapid testing of new agents to treat small cell lung cancer…

  • Memoir Resonates with Oncologists and Patients with Lung Cancer

    Memoir Resonates with Oncologists and Patients with Lung Cancer

    By

    Patient Advocacy & Survivorship

    By Lori Alexander, MTPW, ELS, MWC How does a person with stage IV lung cancer live a meaningful life? That’s the question Paul Kalanithi explores in When Breath Becomes Air, the number 1 book on the New York Times Best Sellers list. Kalanithi’s moving and honest reflection of his life as he transforms from physician…

  • 4th AACR-IASLC International Joint Conference: Lung Cancer Translational Science from the Bench to the Clinic

    4th AACR-IASLC International Joint Conference: Lung Cancer Translational Science from the Bench to the Clinic

    By

    Meeting News

    By Nicola M. Parry, DVM The 4th conference driven by the dynamic collaboration of the International Association for the Study of Lung Cancer (IASLC) and the American Association for Cancer Research (AACR) took place January 4-7 at the Hard Rock Hotel in San Diego, California. Combining the strengths of both organizations, this annual international joint…

  • From the Editor / Corey J. Langer, MD, FACP

    From the Editor / Corey J. Langer, MD, FACP

    By

    Uncategorized

    Greetings. It is my privilege to introduce the IASLC Lung Cancer News (ILCN). I will be serving as Editor with the able assistance of my Associate Editors, Fabrice Barlesi, MD from Europe and Caicun Zhou, MD from Asia. ILCN is a new tabloid publication that will highlight updates on thoracic malignancy research, including diagnostics, screening,…

View ILCN Archives

Provider Resources

Popular Articles